跳至主要内容
临床试验/IRCT20100606004105N30
IRCT20100606004105N30已完成2 期

The effects of zinc gluconate supplementation on several genes expression, the serum level of inflammatory factors, quality of life, and disease activity in patients with Behcet syndrome: double-blind randomized controlled clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Age range 18 to 50 years (premenopausal woman)
  • Diagnosis of Behcet's disease by a rheumatologist according to IBCD (The International Criteria for Behcet’s Disease) which vascular, eyes, and joints complications indicate the severity of the disease
  • Patients who want to participate in the study

排除标准

  • Pregnancy and lactation
  • History of diabetes and other chronic diseases
  • History of other autoimmune diseases
  • Taking nutritional supplements and antioxidants and alpha lipoic acid during the month before the study

研究者

相似试验

Effect of zinc in treatment of Behcet syndrome | 临床试验